Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN Guidelines

Jianfeng Xu1,2,3, Jim Lu4, Marta Gielzak5

  • 1Program for Genomic Translational Research, Endeavor Health, Evanston, Illinois, USA.

The Prostate
|May 23, 2025
PubMed
Summary

Germline genetic testing for prostate cancer (PCa) is recommended for many patients, but evidence for specific genes is limited. This study identifies key genes like BRCA2 and ATM associated with PCa risk and aggressiveness.